NFKB1 and chronic obstructive pulmonary disease: Additionally, Wang W et al. revealed that carbocisteine mitigates hydrogen peroxide-induced inflammation in A549 cells by targeting the NF-κB and ERK1/2 MAPK pathways, offering insights into its potential therapeutic mechanism in COPD [23].